Role of sacubitril/valsartan in testicular ischaemia reperfusion injury via modulation of AngII/ASK/NF‐κB and JAK/STAT pathways in juvenile rats
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70092 ↗At a glance
Journal article in British Journal of Pharmacology, 2025. Written by Marwa Monier Mahmoud Refaie and 6 co-authors. Institution: Department of Medical Pharmacology, Faculty of Medicine, Minia University, El-Minia, Egypt. Major MEDLINE topics: Valsartan, Aminobutyrates, Testis, Tetrazoles. Cited 4 times so far (Crossref); 74 references.
Abstract (original language)
Background and Purpose Testicular torsion is a common urological emergency that affects children and young males and requires immediate surgical intervention and adequate management, or it may lead to male subfertility and infertility with remote effects on vital organs including the heart. To date, there has been no sufficient treatment for these cases, and further studies are highly recommended. Thus, our study aimed to evaluate the effect of sacubitril/valsartan (SV) on testicular ischaemia/reperfusion (TIR)‐induced testicular damage and remote cardiac effect in juvenile rats. Experimental Approach Forty juvenile Wistar albino rats were divided into five groups ( n = 8) as control; SV (60 mg kg −1 ); TIR‐induced group; TIR plus SV low‐dose (30 mg kg −1 ); TIR plus SV high‐dose (60 mg kg −1 ). Key Results TIR induced testicular injury with remote cardiac effects, as we found a significant decrease in serum testosterone, increased cardiac enzyme levels and marked disturbances in oxidative stress parameters. Moreover, there are increases in angiotensin II (Ang II), neprilysin and apoptosis signal‐regulating kinase 1 (ASK1). In addition, there is a disturbance in phosphor‐nuclear factor kappa B (p‐NF‐κB p65), tumour necrosis factor alpha (TNFα), Janus kinase 1 (JAK1), signal transducer and activator of transcription 4 (STAT4) and cleaved caspase 3 with abnormal histological features. However, SV co‐administration reversed damaging effect of TIR by regulating the renin angiotensin aldosterone system (RAAS), and anti‐inflammatory, anti‐oxidant, and anti‐apoptotic pharmacological and physiological properties, and by modulation of different pathways. Conclusions and Implications SV has protective properties against TIR‐induced damage.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Pharmacology, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Medical Physiology, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Histology and cell Biology, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Pediatrics, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Cardiology, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Aswan University, Aswan, Egypt.
Cite
APA
Refaie, M. M. M., Abdel-Hakeem, E. A., Ahmed Ibrahim, R., Hassan Mohamed, Z., Shehata, S., Soltan Shrekawy El Bakry, H., & Ali, D. M. E. (2025). Role of sacubitril/valsartan in testicular ischaemia reperfusion injury via modulation of AngII/ASK/NF‐κB and JAK/STAT pathways in juvenile rats. British Journal of Pharmacology. https://doi.org/10.1111/bph.70092
Vancouver
Refaie MMM, Abdel-Hakeem EA, Ahmed Ibrahim R, Hassan Mohamed Z, Shehata S, Soltan Shrekawy El Bakry H, et al. Role of sacubitril/valsartan in testicular ischaemia reperfusion injury via modulation of AngII/ASK/NF‐κB and JAK/STAT pathways in juvenile rats. British Journal of Pharmacology. 2025. doi:10.1111/bph.70092
BibTeX
@article{Refaie2025,
author = {Refaie, Marwa Monier Mahmoud and Abdel-Hakeem, Elshymaa A and Ahmed Ibrahim, Randa and Hassan Mohamed, Zamzam and Shehata, Sayed and Soltan Shrekawy El Bakry, Hoda and Ali, Doaa Mohamed Elroby},
title = {Role of sacubitril/valsartan in testicular ischaemia reperfusion injury via modulation of AngII/ASK/NF‐κB and JAK/STAT pathways in juvenile rats},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70092}
}
EUVIMED